$PLUS

RAIGUEL DARREN S sold $93 of PLUS (indirect holdings)

RAIGUEL DARREN S (CHIEF OPERATING OFFICER) sold 1 indirectly-held shares of EPLUS INC (PLUS) at $93.44 on 2026-09-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · RAIGUEL DARREN S
Published Sep 24, 2026, 8:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 9:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PLUS
Neutral
high confidence
Mentioned
$PLUS
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLUSNeutralLow
01

Why it matters

The disclosed sale is minimal and does not provide a trading edge.

02

Market read

Low relevance; the transaction size is negligible for market participants.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 2/10Novelty 2/10Timing: filing date 2026-09-24

Background

Form 4 filings disclose insider transactions; a 10b5-1 plan sale by a chief operating officer is routine.

Company-level read

Ticker impact

$PLUSNeutralHigh confidence
Context

COO Raiguel Darren S sold 1 share for $93.44 via a 10b5-1 plan, reducing his holdings to 67,042 shares.

Expected impact

No significant impact expected.

Evidence & confidence

The transaction size is trivial relative to typical float and does not indicate a change in insider sentiment.

Market effects

None; the sale is company‑specific and does not affect the broader sector.

None; limited to the micro‑cap's shareholder base.

None

Counterpoint

Even small insider sales can signal concerns; monitor for further disposals.

Key entities

  • EPLUS INC

    Issuer of the Form 4 filing.

  • Raiguel Darren S

    Chief Operating Officer of EPLUS INC.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CDWMedAI 8/10

Q2 Earnings Outperformers: CDW (NASDAQ:CDW) And The Rest Of The IT Distribution & Solutions Stocks

CDW, ePlus, TD SYNNEX, and ScanSource reported Q2 earnings. CDW (-6%) and ePlus (-10.5%) saw stock declines, while ScanSource (+5.5%) rose. TD SYNNEX (-10.5%) reported strong revenue growth but also fell. ePlus reported flat revenue but beat EPS estimates. ScanSource had the largest analyst estimate beat. TD SYNNEX reported $19.57B revenue, up 31% YoY, and beat EPS estimates and guidance.

$PLUSMed

Plus500 increases buybacks as US growth continues

Plus500 said it will increase shareholder returns via buybacks alongside its half-year results. The company reported double-digit revenue growth year over year and Ebitda up 1% to $188mn. It attributed a lower Ebitda margin (45% to 41%) to higher marketing spend to attract new customers, while expanding in US futures.

$PLUSMedAI 8/10

Why ePlus (PLUS) Shares Are Plunging Today

ePlus (NASDAQ: PLUS) shares fell about 5% after the company reported Q2 2026 results. Revenue rose 1.9% year over year to $649.1 million and adjusted EPS was $1.28, both above Wall Street estimates. Despite the beat, investors focused on declining adjusted operating and free cash flow margins and a forecast of about 2% full-year EPS growth. Shares later traded near $92.31.